Prenatal multivitamin use and mthfr genotype are associated with newborn cord blood dna methylation

Kelly M. Bakulski, John F. Dou, Jason I. Feinberg, Katharine K. Brieger, Lisa A. Croen, Irva Hertz-Picciotto, Craig J. Newschaffer, Rebecca J. Schmidt, M. Daniele Fallin

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Fetal development involves cellular differentiation and epigenetic changes —complex processes that are sensitive to environmental factors. Maternal nutrient levels during pregnancy affect development, and methylene tetrahydrofolate reductase (MTHFR) is important for processing the nutrient folate. Hypothesis: We hypothesize that supplement intake before pregnancy and maternal genotype are associated with DNA methylation in newborns. Methods: In the pregnancy cohort, Early Autism Risk Longitudinal Investigation (EARLI), health history, and genotype information was obtained (n = 249 families). Cord blood DNA methylation (n = 130) was measured using the Illumina HumanMethylation450k array and global DNA methylation levels were computed over 455,698 sites. Supplement use preconception and during pregnancy were surveyed at visits during pregnancy. We evaluated associations between maternal preconception supplement intake and global DNA methylation or DNA methylation density distributions of newborn cord blood, stratified by the presence of a variant maternal MTHFR C677T allele. Results: Maternal preconceptional multivitamin intake was associated with cord blood methylation, dependent on maternal MTHFR genotype (interaction term p = 0.013). For mothers without the MTHFR variant allele, multivitamin intake was associated with 0.96% (95% CI: 0.09, 1.83) higher global cord blood methylation (p = 0.04) and was also associated with the cumulative density distribution of methylation (p = 0.03). For mothers with at least one variant allele, multivitamin intake had a null −0.06% (95% CI: −0.45, 0.33) association with global cord blood DNA methylation, and was not associated with the cumulative density distribution (p = 0.37). Conclusions: We observed that cord blood DNA methylation was associated with maternal supplement exposure preconception and maternal genotype. Genetic context should be considered when assessing DNA methylation effects of modifiable risk factors around the time of pregnancy.

Original languageEnglish (US)
Article number9190
Pages (from-to)1-16
Number of pages16
JournalInternational journal of environmental research and public health
Volume17
Issue number24
DOIs
StatePublished - Dec 2 2020

Keywords

  • Cord blood
  • DNA methylation
  • MTHFR
  • Multivitamin

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health, Toxicology and Mutagenesis

Fingerprint Dive into the research topics of 'Prenatal multivitamin use and mthfr genotype are associated with newborn cord blood dna methylation'. Together they form a unique fingerprint.

Cite this